scispace - formally typeset
W

Waasila Jassat

Researcher at National Health Laboratory Service

Publications -  74
Citations -  1689

Waasila Jassat is an academic researcher from National Health Laboratory Service. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 6, co-authored 17 publications receiving 120 citations. Previous affiliations of Waasila Jassat include University of the Western Cape.

Papers
More filters
Journal ArticleDOI

The COVID-19 crisis in South Africa: Protecting the vulnerable.

Lucille Blumberg, +3 more
- 08 Jul 2020 - 
TL;DR: This page provides information about preventing and reducing the spread of the SARS-CoV-2 virus that causes COVID-19 among school staff, and maintaining healthy school operations and the exposure risk among K-12 school staff.
Journal ArticleDOI

ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19

Ali E. Abbas, +1772 more
- 30 Jul 2022 - 
TL;DR: The International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC) COVID-19 dataset as mentioned in this paper is one of the largest international databases of prospectively collected clinical data on people hospitalized with COVID19.
Posted ContentDOI

Sentinel seroprevalence of SARS-CoV-2 in the Gauteng province, South Africa August to October 2020.

Jaya A. George, +12 more
- 29 Apr 2021 - 
TL;DR: In this paper, a sentinel study was conducted using remnant serum samples received at three National Health Laboratory Services laboratories situated in the City of Johannesburg (COJ) district, South Africa.
Journal ArticleDOI

SARS-CoV-2 Seroprevalence after Third Wave of Infections, South Africa

Jackie Kleynhans, +18 more
- 23 Mar 2022 - 
TL;DR: High seroprevalence before the Omicron variant emerged may have contributed to reduced illness severity observed in the fourth wave of severe acute respiratory syndrome coronavirus 2 infections in South Africa.
Posted ContentDOI

Higher mortality associated with the SARS-CoV-2 Delta variant in the Western Cape, South Africa, using RdRp target delay as a proxy

Hannah Hussey, +34 more
- 26 Oct 2021 - 
TL;DR: A novel proxy for the Delta variant, RNA-dependent RNA polymerase target delay in the Seegene Allplex™ 2019-nCoV PCR assay, was associated with higher mortality (adjusted Odds Ratio 1.45 [95%CI 1.13-1.86]), compared to presumptive Beta infection in the Western Cape, South Africa (April-July 2021).